And today I’m going to show you some great examples of “Silicon Valley Watch List” companies that turned into mega-deal buyouts – and demonstrate how you can set up your portfolio to grab a share of these tech-sector windfalls.
The Internet of Everything, a vast network of devices like phones, watches, clothing and even toothbrushes – all communicating, all collecting and returning data – has been one of the biggest tech stories of the past five years.
But I’m here to tell you that it’s about to get even bigger, even more profitable, by an order of magnitude. That’s because the Internet of Everything is about to crack open the healthcare market, with small networked wearable medical, prosthetic, and therapeutic devices set to explode onto the market.
I’m talking about wearable therapeutics – or “wearapeutics.” It’s going to be a healthcare game changer.
Today, I’m showing you just how big the wearapeutics market is going to get – and the one investment you need to hold long term to get the most profits out of this exciting development.
This is just a quick note to let you know that I’m still at work on the big project I mentioned earlier this week.
I’m putting this special series together because I’ve done a great deal of research about a specific technology – and that research has revealed that this breakout tech threatens the livelihoods and fortunes of a huge chunk of humanity.
That may sound scary.
However, that same research has also revealed ways that tech investors can protect themselves and their families from this dire threat – and to build even more wealth.
I’ll be back next week with the start of this series.
But in the meantime, I need some help from you, the members of the Strategic Tech Investor family.
Amid all the breaking news about the layoffs at Cisco Systems Inc. (Nasdaq: CSCO) this week, I appeared on CNBC World to share my thoughts. I let that audience know what’s behind Cisco’s layoffs – and shared my thoughts on what investors should do with their stock (and why Cisco’s fat dividend matters here).
Now I want to share all that with you folks as well. Just click here.
I'm working on a big project this week - immersed in research and writing. I believe the investments that this series reveals will be hugely profitable for all of you - but I have to take a bit of a break this week in order to complete it. But...
Investors who live in a “five-day” world have a mighty short collective memory. In the markets, a month might as well be a century.
Certainly no one in the financial media is looking back to June 24, 2016, anymore. But as you’ll see, that could be a costly mistake.
That’s the day after the United Kingdom’s historic European Union membership referendum ended in a shock “Leave” result. It was also the day global markets plunged by more than 5%, wiping out trillions in wealth, and sending the pound sterling to multi-decade lows.
Then again, because U.S. markets have gone on a historic rocket ride in the weeks since, it’s understandable that investors have “forgotten” the Brexit’s initial shock and moved on.
Now that might be okay… if only for the fact that the U.K. hasn’t actually done anything yet. And there are ominous signs that things could get downright ugly as the day it actually leaves the EU approaches. It has the potential to make the Brexit vote shock look tame by comparison.
That means there’s plenty of time (and upside) left in the “high-tech gold” defense maneuver I’m about to show you
Not all “unstoppable trends” in the tech sector have to do with technology itself. Just take a look…
On Aug. 1, we learned that Verizon Communications Inc. (NYSE: VZ) is buying Fleetmatics Group PLC (NYSE: FLTX) in a $2.8 billion deal. The tie-up puts Verizon into the business of helping companies with fleets of delivery vehicles track and analyze data.
That came just one week after Verizon agreed to pick up the web assets and patents (and some real estate) of Yahoo Inc. (Nasdaq: YHOO) for $4.83 billion.
In other words, another day, another multibillion-dollar tech merger…
Indeed, mergers and acquisitions (M&A) that allow firms to enter new markets and add more growth are an unstoppable trend.
Recall the mid-June announcement from Microsoft Corp. (Nasdaq: MSFT) that it’s buying LinkedIn Corp. (NYSE: LNKD) for $26.2 billion in a pact that moves Satya Nadella’s software/mobile/cloud computing firm into business-focused social networking.
Over the long run, these M&A deals can really help the acquirers beat their competitors and boost their share prices by boosting sales and profit margins.
And they can do the same for investors.
But they also pose a challenge: How do you predict who will buy whom – and when such deals will be announced?
Usually, you can’t.
But I have an “end run” around that problem – one that will help you boost your earnings via M&A… without having to consult a crystal ball.
Deep inside your body, skin, joints and muscles deliver messages to your spinal cord, which uses that information to control your movements. Further, your ears, eyes, mouth, nose and skin deliver messages to your brain, which allows you to react, think and plan – and then direct your body to carry out your decisions.
That’s the central nervous system.
And those messages come in the form of electric signals.
For decades, doctors have dreamed of being able to harness those electric signals to treat injuries and disease.
And now, thanks to miniature implantable devices that can alter and control the body’s electric signals, that dream is coming true.
Researchers are calling it “bioelectronic medicine.”
Here’s how it will work.
Take, for example, a child with asthma. With bioelectronics, doctors could wrap tiny devices around nerves in the lungs. Employing those devices, doctors could then alter nervous electric signals in order to ease tension in the lungs.
If everything goes right, no more asthma…
And asthma treatments are just the beginning…
Researchers from the company I want to share with you today are confident bioelectronic medicine can also be used to treat other long-term diseases, including diabetes and arthritis.
And now this company is teaming up with Google parent Alphabet, Inc. (Nasdaq: GOOGL) to forge a brand-new $715 million bioelectronics firm.
Those of you who invested in this company back on March 29, when I first told you about it, have already made more than 11% on your money. That’s nearly double the S&P 500’s return over the same period.
And now this pact with Alphabet puts it in line to continue this strong growth, as it helps you get invested in bioelectronics – a sector that Global Market Insights says is growing at more than 10% a year, 10 times faster than the U.S. economy as a whole.